Search Results

You searched for : GLP

	Sanofi’s diabetes drug Soliqua® now available in India A simple to initiate once-daily solution that breaks through the complexity of living with type 2 diabetes. Nominal therapy cost enables wider access to ... Apr 30
	Biocon Ventures into Weight-Loss Drug Market with Semaglutide Development Biocon's foray into the weight-loss drug market aligns with its significant investment in generics research and development, with a notable focus on peptides ... Apr 20
	Hope for Parkinson’s Patients: Diabetes Drug Lixisenatide Shows Promise in Slowing Disease Progression The potential of repurposing existing medications, such as lixisenatide, to target Parkinson’s disease progression represents a significant stride forward in neurological research.... Apr 05
	Empowering India's Healthcare: Dr. Sujit Paul Unveils Davaindia's Commitment to Quality and Affordability Dr. Paul highlighted that the generic sector of pharmaceutical companies currently holds a substantial portion of the Indian pharmaceutical market, exhibiting a growth rate approximately ... Jan 27
	FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ... Nov 17
	Pills or Insulin â€“ Which works best for diabetes management? Of the various factors that contribute to diabetes, a sedentary lifestyle and improper intake of food constitute the major ones. Thus, along with drugs, insulin, ... Jan 04
	BioVaxys enters into a major bioproduction agreement with Wuxi Biologics (Hong Kong) Ltd. ... Mar 16
	Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment Hoth Therapeutics, Inc. a biopharmaceutical company, today announced that it has signed a production agreement for both GLP and GMP materials associated with HT-001 ... Jan 01
	I2O Therapeutics receives strategic investment from Colorcon Ventures Colorcon will collaborate with i2O to accelerate i2Oâ€™s research and development efforts... Dec 04
	Cabinet approves Memorandum of Understanding between India and United Kingdom on cooperation in the field of Medical Products Regulation The MoU will help in establishing a framework for fruitful cooperation and exchange of information between the Central Drugs Standard Control Organization (CDSCO) and the ... Nov 04
	Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million... Oct 29
	GigaGen Initiates large-scale manufacturing of it's COVID-19, drug GIGA-2050 GIGA-2050 is a new class of drug designed to provide passive immunity to COVID-19 patients or those at high risk.... Sep 16
	Brink Biologics announces license agreement with Fresenius Kabi SwissBioSim GmbH Brink Bilogics licenses bioanalytical testing solution to Fresenius Kabi SwissBioSim GmbH... Sep 11
	Potential therapeutics for COVID-19 should be tested for auditory safety The class of drugs used in covid treatment may result in loss of auditory senses... Sep 07
	Best Foods to Control Blood Sugars Studies have proved thatÂ cinnamon can bring down glucose levels and improve insulin affectability, but you should restrict your admission of cinnamon to under 1 ... Sep 03
	Gufic Lifesciences signs contract with Hetero Labs for Remdesivir lyophilised powder Gufic Lifesciences has entered into a loan agreement with Hetero Labs Limited to manufacture and supply Remdesivir lyophilised powder ... Aug 12
	Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors Post-hoc analysis of the EMPA-REG OUTCOMEÂ® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ... Sep 20
	Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 ... Sep 13
	Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA Aptorum Group Limited (Nasdaq: APM) (â€œAptorum Groupâ€), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that ... Sep 12
19 Matching result(s) found!

-Advertisements-

Trending Now
	Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
	Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
	Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
	Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
	Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
	Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
	Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
	Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
	TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
	The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
	Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024
	The Future of Healthcare: 10 ways Telehealth is Improving Patient Outcomes and Reducing CostsMay 03, 2024
	Understanding the Effects of a Keto Diet on Your Body: A One-Month JourneyMay 03, 2024
	High Blood Pressure in Youth: A Precursor to Severe Heart ConditionsMay 03, 2024
	High Blood Pressure in Youth: A Precursor to Severe Heart ConditionsMay 03, 2024
	Microplastics in Human Brains: Understanding the Emerging Health ConcernMay 03, 2024
	Federal Bank Wraps Up FY 24 With 24% Rise in Profit, highest NII, Maintains Robust Asset QualityMay 02, 2024
	Two Aveksha Day Care Centers for Construction Workers’ Children opened on the occasion of Labour Day May 02, 2024
	AbbVie India and Sightsavers India Collaborate to Raise Awareness on GlaucomaMay 02, 2024
	Whither social justice and decent work for women?May 02, 2024

Search Results

Sanofi’s diabetes drug Soliqua® now available in India

Biocon Ventures into Weight-Loss Drug Market with Semaglutide Development

Hope for Parkinson’s Patients: Diabetes Drug Lixisenatide Shows Promise in Slowing Disease Progression

Empowering India's Healthcare: Dr. Sujit Paul Unveils Davaindia's Commitment to Quality and Affordability

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

Pills or Insulin â€“ Which works best for diabetes management?

BioVaxys enters into a major bioproduction agreement with Wuxi Biologics (Hong Kong) Ltd.

Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment

I2O Therapeutics receives strategic investment from Colorcon Ventures

Cabinet approves Memorandum of Understanding between India and United Kingdom on cooperation in the field of Medical Products Regulation

Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million

GigaGen Initiates large-scale manufacturing of it's COVID-19, drug GIGA-2050

Brink Biologics announces license agreement with Fresenius Kabi SwissBioSim GmbH

Potential therapeutics for COVID-19 should be tested for auditory safety

Best Foods to Control Blood Sugars

Gufic Lifesciences signs contract with Hetero Labs for Remdesivir lyophilised powder

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility

Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA

Trending Now